Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes

Valeria Paradies1, Adrian Banning2, Davide Cao3

  • 1Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands; Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, the Netherlands.

Insights

Percutaneous coronary intervention is a viable treatment for unprotected left main coronary artery disease. This review examines optimal stenting strategies for left main bifurcation lesions, focusing on provisional stenting and two-stent techniques.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Left main coronary artery (LMCA) disease affects a significant myocardial area, increasing adverse cardiovascular event risk.
  • LMCA disease is diagnosed in 5-7% of coronary angiographies, with most complex cases involving distal bifurcation/trifurcation.
  • Percutaneous coronary intervention (PCI) is emerging as a treatment for unprotected LMCA disease, yet optimal stenting strategies remain undefined.

Purpose of the Study:

  • To review current evidence on PCI strategies for LMCA bifurcation lesions.
  • To compare provisional stenting with two-stent techniques for LMCA bifurcation disease.
  • To summarize optimal techniques and factors influencing strategy selection in LMCA stenting.

Main Methods:

  • Review of data from randomized controlled trials and prospective registries.
  • Analysis of technical aspects of provisional stenting for LMCA bifurcation.
  • Summary of angiographic and intravascular imaging determinants for escalating to two-stent strategies.

Main Results:

  • PCI is a feasible treatment option for selected patients with unprotected LMCA disease.
  • Evidence supports provisional stenting as a primary strategy, with defined criteria for escalation.
  • Optimal techniques and imaging guidance are crucial for successful LMCA bifurcation stenting.

Conclusions:

  • Provisional stenting is a key strategy for LMCA bifurcation lesions, with specific technical considerations.
  • Escalation to two-stent techniques is guided by lesion complexity and imaging findings.
  • Further research is needed to standardize optimal stenting approaches for LMCA bifurcation disease.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
13
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
29